חזרה לתוצאות החיפוש

A Beta-only IL-2 ImmunoTherapY Study

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Advanced Solid Tumor · Unresectable Solid Tumor · Clear Cell Renal Cell Carcinoma · Triple Negative Breast Cancer · Non-Small Cell Lung Cancer Squamous · Non-Small Cell Lung Cancer Non-squamous · Colorectal Cancer (MSI-H) · Gastric Cancer · Cervical Cancer · Basal Cell Carcinoma · Bladder Cancer · Merkel Cell Carcinoma · Squamous Cell Carcinoma of Head and Neck · Cutaneous Squamous Cell Carcinoma · Pleural Mesothelioma · Esophageal Cancer · Endometrial Carcinoma · Solid Tumor · Solid Tumor, Adult · MSI-H Solid Malignant Tumor · Cancer With A High Tumor Mutational Burden · Epithelial Ovarian Carcinoma · Primary Peritoneal Cancer · Gastroesophageal Junction (GEJ) Cancer · Acral Melanoma · Mucosal Melanoma · Cutaneous Melanoma · DMMR Solid Malignant Tumor · Fallopian Tube Cancer · Ovarian Cancer · MSI-H Cancer · DMMR Cancer · Pancreas Adenocarcinoma (MSI-H) · Skin Cancer · Viral Cancer · Cervical Cancers · Endometrial Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Sharp Memorial Hospital, San Diego, California, United States

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

  • Providence Saint John's Health Center, Santa Monica, California, United States

  • Boca Raton Regional Hospital, Boca Raton, Florida, United States

  • Emory - Winship Cancer Institute, Atlanta, Georgia, United States

  • Karmanos Cancer Institute, Detroit, Michigan, United States

  • MD Anderson Cancer Center, Houston, Texas, United States

  • Scientia Clinical Research, Randwick, New South Wales, Australia

  • Macquarie University, Sydney, New South Wales, Australia

  • University of the Sunshine Coast, Buderim, Queensland, Australia

  • Gallipoli Medical Research Foundation, Greenslopes, Queensland, Australia

  • Princess Margaret Cancer Center, Toronto, Ontario, Canada

  • Mater Misericordiae University Hospital, Dublin, Ireland

  • START Lisbon - Centro de Ensaios Clínicos, ULS Sta Maria, Lisbon, Portugal

  • Instituto Portugues De Oncologia Do Porto, Porto, Portugal

  • Samsung Medical Center, Seoul, Gangnam-gu, South Korea

  • Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea

  • The Catholic University of Korea St. Vincent Hospital, Suwon, Gyeonggi-do, South Korea

  • Seoul National University Hospital, Seoul, Jongno-gu, South Korea

  • Institut Catala d'Oncologia (ICO)-Badalona, Badalona, Spain

  • START Barcelona / HM Nou Delfos, Barcelona, Spain

  • Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  • Hospital Universitario Ramón y Cajal, Madrid, Spain

  • START Madrid / Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain

  • Hospital Universitario Hm Sanchinarro, Madrid, Spain

  • Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain

  • Hospital Universitario de Torrejon, Torrejón, Spain

מובילי המחקר

  • Nina Merchant

    Study Director

    Medicenna Therapeutics

  • Arash Yavari, MBBS

    Study Chair

    Medicenna Therapeutics

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)